4
Changes in Ownership
Amylyx Pharmaceuticals, Inc. Filed Acc 0000950170-24-122640
Co-Chief Executive Officer acquired 63,690 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Klee Justin B. Co-Chief Executive Officer | 2024-11-04 | Option exercise | +63,690 | $1.57 | $99,993 | 3,184,259 | D |
| Derivatives | |||||||
| Klee Justin B. Co-Chief Executive Officer | 2024-11-04 | Option exercise · Stock Option (right to buy) | −63,690 | 36,310 | D | ||
Loading xslF345X05/ownership.xml…